Advertisement

Psychopharmacology

, Volume 112, Issue 2–3, pp 324–330 | Cite as

Subjective and behavioral effects of diazepam depend on its rate of onset

  • Harriet de Wit
  • Susan Dudish
  • John Ambre
Original Investigations

Abstract

This study addressed the assumption that rate of onset affects the euphorigenic effects of drugs. Drugs with rapid onset are commonly thought to be more euphorigenic than drugs with slower onset, but this idea has rarely been studied directly. Nine healthy male social drinkers, with no history of drug- or alcohol-related problems, participated in three sessions. On each session they received oral doses of placebo (PLAC), diazepam in a rapid onset condition (FAST), or diazepam in a slow onset condition (SLOW). In the FAST condition, they received a single 20 mg dose, whereas in the SLOW condition they received six 4 mg doses administered at 30-min intervals. Plasma levels of diazepam and desmethyldiazepam, subjective effects (including measures of euphoria), psychomotor performance and vital signs were monitored throughout each session. Although the FAST and SLOW conditions led to similar peak plasma levels of drug, the peak was attained earlier in the FAST condition (61 min versus 220 min). Subjects' scores on a measure of euphoria (MBG scale of the ARCI) were significantly higher in the FAST condition compared to the SLOW and PLAC conditions. Subjects exhibited significantly more behavioral signs of intoxication and greater psychomotor impairment in the FAST condition. Sedative effects of the drug were similar in magnitude, but the effects lasted slightly longer in the FAST condition. On several measures diazepam produced similar effects in the two conditions (e.g., ratings of strength of drug effect). These data provide limited support for the notion that a faster rate of onset of drug effects is associated with greater euphoria.

Key words

Oral diazepam Pharmacokinetics Subjective effects Euphoria Humans Abuse potential Normal volunteers Rate of onset 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association, Washington, DCGoogle Scholar
  2. American Psychiatric Association (1990) Benzodiazepine dependence, toxicity, and abuse: a Task Force Report of the American Psychiatric Association. American Psychiatric Association, Washington, DCGoogle Scholar
  3. Bertilsson L, Henthorn TK, Sanz E, Tybring G, Säwe J, Villén T (1989) Importance of genetic factors in the regulation of diazepam metabolism: relationship toS-mephenytoin, but not debrisoquin, hydroxylation phenotype. Clin Pharmacol Ther 45:348–355Google Scholar
  4. Bliding A (1974) Effects of different rates of absorption of two benzodiazepines on subjective and objective parameters. Eur J Clin Pharmacol 7:201–211Google Scholar
  5. Busto U, Sellers EM (1986) Pharmacokinetic determinants of drug abuse and dependence. Clin Pharmacokinet 11:144–153Google Scholar
  6. Derogatis L (1983) SCL-90-R Manual-II. Clinical Psychometric Research, Towson, MDGoogle Scholar
  7. de Wit H (1991) Diazepam preference in males with and without an alcoholic first-degree relative. Alcohol Clin Exp Res 15:593–600Google Scholar
  8. de Wit H, Griffiths RR (1991) Methods of assessing the abuse liability of sedatives in humans. Drug Alcohol Depend 28:83–111Google Scholar
  9. de Wit H, Pierri J, Johanson CE (1989) Reinforcing and subjective effects of diazepam in non-drug-abusing volunteers. Pharmacol Biochem Behav 33:205–213Google Scholar
  10. de Wit H, Bodker B, Ambre J (1992) Rate of increase of plasma drug level influences subjective response in humans. Psychopharmacology 107:352–358Google Scholar
  11. Farré M, Camí J (1991) Pharmacokinetic considerations in abuse liability evaluation. Br J Addict 86:1601–1606Google Scholar
  12. Funderburk FR, Griffiths RR, McLeod DR, Bigelow GE, Mackenzie A, Liebson IA, Nemeth-Coslett R (1988) Relative abuse liability of lorazepam and diazepam: an evaluation in “recreational” drug users. Drug Alcohol Depend 22:215–222Google Scholar
  13. Ghoneim MD, Mewaldt SP (1990) Benzodiazepines and human memory: a review. Anesthesiology 72:926–938Google Scholar
  14. Greenblatt DJ, Sethy VH (1990) Benzodiazepine concentrations in brain directly reflect receptor occupancy: studies of diazepam, lorazepam, and oxazepam. Psychopharmacology 102:373–378Google Scholar
  15. Greenblatt DJ, Shader RI (1987) Pharmacokinetics of antianxiety agents. In: Meltzer HY (ed.) Psychopharmacology: The Third Generation of Progress. Raven, New York, pp 1377–1386Google Scholar
  16. Greenblatt DJ, Shader RI, Hermatz JS, Franke K, Koch-Weser J (1977) Absorption rate, blood concentrations, and early response to oral chlordiazepoxide. Am J Psychiatry 134:559–562Google Scholar
  17. Greenblatt DJ, Ochs HR, Lloyd BL (1980) Entry of diazepam and its major metabolite into cerebrospinal fluid. Psychopharmacology 70:89–93Google Scholar
  18. Greenblatt DJ, Arendt RM, Shader RI (1984) Pharmacodynamics of benzodiazepines after single oral doses: kinetic and physiochemical correlates. In: Hindmarch I, Ott H, Roth T (eds) Sleep, benzodiazepines and performance. Springer, Berlin Heidelberg New York, pp 92–97Google Scholar
  19. Greenblatt DJ, Harmatz JS, Friedman H, Locniskar A, Shader RI (1989) A large-sample study of diazepam pharmacokinetics. Ther Drug Monit 11:652–657Google Scholar
  20. Griffiths RR, Wolf B (1990) Relative abuse liability of different benzodiazepines in drug abusers. J Clin Psychopharmacol 10:237–243Google Scholar
  21. Griffiths RR, Bigelow GE, Liebson I, Kaliszak JE (1980) Drug preference in humans: double-blind choice comparison of pentobarbital, diazepam and placebo. J Pharmacol Exp Ther 215:649–661Google Scholar
  22. Griffiths RR, McLeod DR, Bigelow GE, Liebson IA, Roache JD, Nowowieski P (1984) Comparison of diazepam and oxazepam: preference, liking and extent of abuse. J Pharmacol Exp Ther 229:501–508Google Scholar
  23. Jaffe JH (1990) Drug addiction and drug abuse. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) Goodman and Gilman's The Pharmacological Basis of Therapeutics. Pergamon, New York, pp 522–573Google Scholar
  24. Johanson CE, Uhlenhuth EH (1980) Drug preference and mood in humans: diazepam. Psychopharmacology 71:269–273Google Scholar
  25. Jones DR, Hall SD, Jackson EK, Branch RA, Wilkinson GR (1988) Brain uptake of benzodiazepines: effects of lipophilicity and plasma protein binding. J Pharmacol Exp Ther 245:816–822Google Scholar
  26. Kaplan SA, Jack ML, Alexander K, Weinfeld RE (1973) Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations. J Pharm Sci 62:1789–1796Google Scholar
  27. Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971) Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clin Pharmacol Ther 12:245–258Google Scholar
  28. Mattila M (1988) Acute and subacute effects of diazepam on human performance: comparison of plain tablet and controlled release capsule. Pharmacol Toxicol 63:369–374Google Scholar
  29. McLeod DR, Hoehn-Saric R, Labib AS, Greenblatt DJ (1988) Six weeks of diazepam treatment in normal women. J Clin Psychopharmacol 8:83–99Google Scholar
  30. McNair D, Lorr M, Droppleman L (1971) Profile of mood states (manual). Educational and Industrial Testing Service, San DiegoGoogle Scholar
  31. Parrott AC, Hindmarch I (1980) The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations — a review. Psychopharmacology 71:173–179Google Scholar
  32. Salonen M, Aantaa E, Aaltonen L, Hovi-Viander M, Kanto J (1986) A comparison of the soft gelatin capsule and the tablet form of temazepam. Acta Pharmacol Toxicol 58:49–54Google Scholar
  33. Tuomainen P (1989) A methodological comparison of two formulations of temazepam in pharmacokinetic and pharmacodynamic aspects. Pharmacol Toxicol 64:28–32Google Scholar
  34. Wechsler D (1958) The measure and appraisal of adult intelligence. Williams and Wilkins, BaltimoreGoogle Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • Harriet de Wit
    • 1
  • Susan Dudish
    • 1
  • John Ambre
    • 2
  1. 1.Department of PsychiatryThe University of ChicagoChicagoUSA
  2. 2.American Medical AssociationChicagoUSA

Personalised recommendations